Isotracin (Isotretinoin)

Isotretinoin binds to retinoic acid receptors in skin cells, altering gene expression. This leads to smaller sebaceous glands, reduced sebum output, normalized follicular keratinization, and anti‑inflammatory effects, all of which target the core mechanisms that cause acne.

The dose of Isotracin is individualized by the prescribing clinician based on factors such as body weight, acne severity, and laboratory results. Physicians typically start with a low dose and adjust according to response and tolerability, following established dermatology guidelines.

Isotracin is classified as pregnancy category X because isotretinoin is highly teratogenic. It must not be used during pregnancy, and effective contraception is required for women of child‑bearing potential. Use during breastfeeding is also discouraged, as the drug can be excreted in milk.

To order Isotracin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with oral antibiotics, isotretinoin offers a disease‑modifying effect rather than merely suppressing bacterial growth. Unlike topical retinoids, it reaches deeper skin layers systemically, providing greater efficacy for severe cases. However, its safety profile requires more intensive monitoring.

Isotracin should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments.

Isotracin is taken orally, usually with a full glass of water. It can be taken with or without food, but consistent intake with respect to meals helps maintain stable absorption. Patients should follow the prescribing clinician’s instructions regarding timing and any dietary considerations.

The most serious risks include severe depression or suicidal thoughts, teratogenic effects leading to birth defects, inflammatory bowel disease exacerbation, and rare cases of intracranial hypertension. Patients should report any mood changes, persistent abdominal pain, or visual disturbances to their healthcare provider promptly.

Isotracin is contraindicated in pregnant women, women planning pregnancy, and nursing mothers. It should also be avoided in patients with uncontrolled liver disease, severe hyperlipidemia, or known hypersensitivity to isotretinoin or any component of the formulation.